Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Argent Biopharma (RGTLF)
OTHER OTC:RGTLF
Holding RGTLF?
Track your performance easily
RGTLF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.12 - $1.40
Previous Close$0.23
Volume88.00
Average Volume (3M)261.79K
Market Cap
$10.65M
Enterprise Value$10.45M
Total Cash (Recent Filing)AU$239.82K
Total Debt (Recent Filing)AU$575.14K
Price to Earnings (P/E)―
Beta-2.61
Next Earnings
Feb 26, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.31
Shares Outstanding3,198,519
10 Day Avg. Volume67
30 Day Avg. Volume261,791
Standard Deviation0.42
R-Squared0.00069
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)102.63
Price to Cash Flow (P/CF)-23.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Argent Biopharma News
PremiumCompany Announcements
Argent Biopharma Director Bolsters Stake
PremiumCompany Announcements
Argent BioPharma’s CannEpil® Shows Seizure Management Promise
PremiumCompany Announcements
Argent BioPharma Advances CimetrA® DevelopmentPremiumCompany Announcements
Argent Biopharma Targets CNS and Autoimmune Innovations
PremiumCompany Announcements
Argent BioPharma Unveils Preliminary FinancialsPremiumCompany Announcements
Argent BioPharma Schedules Shareholder Meeting
PremiumCompany Announcements
Argent BioPharma Pioneers Advanced Medical TreatmentsPremiumCompany Announcements
Argent BioPharma Targets Chronic Wound CareRGTLF FAQ
What was Argent Biopharma’s price range in the past 12 months?
Argent Biopharma lowest stock price was $0.12 and its highest was $1.40 in the past 12 months.
What is Argent Biopharma’s market cap?
Currently, no data Available
When is Argent Biopharma’s upcoming earnings report date?
Argent Biopharma’s upcoming earnings report date is Feb 26, 2025 which is in 159 days.
How were Argent Biopharma’s earnings last quarter?
Argent Biopharma released its earnings results on Aug 30, 2024. The company reported -$0.112 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.112.
Is Argent Biopharma overvalued?
According to Wall Street analysts Argent Biopharma’s price is currently Overvalued.
Does Argent Biopharma pay dividends?
Argent Biopharma does not currently pay dividends.
What is Argent Biopharma’s EPS estimate?
Argent Biopharma’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Argent Biopharma have?
Argent Biopharma has 48,405,600 shares outstanding.
What happened to Argent Biopharma’s price movement after its last earnings report?
Argent Biopharma reported an EPS of -$0.112 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -25.926%.
Which hedge fund is a major shareholder of Argent Biopharma?
Currently, no hedge funds are holding shares in RGTLF
---
Argent Biopharma Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bearish
RGTLF Sentiment 100%
Sector Average 71%
Sector Average 71%
Insider Transactions
Bought Shares
Worth $340.7K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
8.41%
Trailing 12-Months
Company Description
Argent Biopharma
MGC Pharmaceuticals Ltd is a European-based specialist Medical Cannabis company, in Phytocannabinoid-based medicine within the biopharmaceutical industry. The company's principal business goal is to produces and supply quality Cannabinoid based pharmaceutical products for the emergent medical markets in Europe, North America and Australasia.
---
Technical Analysis
---